These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 12835944)

  • 1. Etiopathogenesis of cholesteatoma.
    Olszewska E; Wagner M; Bernal-Sprekelsen M; Ebmeyer J; Dazert S; Hildmann H; Sudhoff H
    Eur Arch Otorhinolaryngol; 2004 Jan; 261(1):6-24. PubMed ID: 12835944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of bone resorption in the etiopathogenesis of acquired middle ear cholesteatoma.
    Xie S; Wang X; Ren J; Liu W
    Eur Arch Otorhinolaryngol; 2017 May; 274(5):2071-2078. PubMed ID: 27981350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor beta and wound healing in human cholesteatoma.
    Huisman MA; de Heer E; Ten Dijke P; Grote JJ
    Laryngoscope; 2008 Jan; 118(1):94-8. PubMed ID: 17989584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired cholesteatoma: summary of the cascade of molecular events.
    Louw L
    J Laryngol Otol; 2013 Jun; 127(6):542-9. PubMed ID: 23656971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current concepts of the pathogenesis of acquired middle ear cholesteatoma].
    Welkoborsky HJ
    Laryngorhinootologie; 2011 Jan; 90(1):38-48; quiz 49-50. PubMed ID: 21225533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Middle ear cholesteatoma: present-day concepts of etiology and pathogenesis].
    Lesinskas E; Kasinskas R; Vainutiene V
    Medicina (Kaunas); 2002; 38(11):1066-71; quiz 1141. PubMed ID: 12532718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunomodulation in Cholesteatoma].
    Leichtle A; Leffers D; Daerr MG; Draf C; Kurabi A; Ryan AF; Rupp J; Bruchhage KL
    Laryngorhinootologie; 2022 Apr; 101(4):310-319. PubMed ID: 34233375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Research progress of the cholesteatoma and proliferation pathways].
    Wang J; Wei XL
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Sep; 53(9):703-708. PubMed ID: 30293269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of perimatrix fibroblasts in development of acquired middle ear cholesteatoma. A hypothesis].
    Milewski C
    HNO; 1998 May; 46(5):494-501. PubMed ID: 9647920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between individual ossicular status and conductive hearing loss in cholesteatoma.
    Martins O; Victor J; Selesnick S
    Otol Neurotol; 2012 Apr; 33(3):387-92. PubMed ID: 22410730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Keratinocyte growth factor signaling promotes stem/progenitor cell proliferation under p63 expression during middle ear cholesteatoma formation.
    Yamamoto-Fukuda T; Akiyama N
    Curr Opin Otolaryngol Head Neck Surg; 2020 Oct; 28(5):291-295. PubMed ID: 32796271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired cholesteatoma epithelial hyperproliferation: Roles of cell proliferation signal pathways.
    Xie S; Xiang Y; Wang X; Ren H; Yin T; Ren J; Liu W
    Laryngoscope; 2016 Aug; 126(8):1923-30. PubMed ID: 26989841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etiopathogenesis of acquired cholesteatoma: prominent theories and recent advances in biomolecular research.
    Kuo CL
    Laryngoscope; 2015 Jan; 125(1):234-40. PubMed ID: 25123251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The relationship between ossicular status and conductive hearing loss in cholesteatoma].
    Ye F; Zhao K; Chen B; Gao P; Wang X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Jul; 27(13):701-3. PubMed ID: 24073577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aural cholesteatoma: role of tumor necrosis factor-alpha in bone destruction.
    Sastry KV; Sharma SC; Mann SB; Ganguly NK; Panda NK
    Am J Otol; 1999 Mar; 20(2):158-61. PubMed ID: 10100515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biology of cholesteatoma: special considerations in pediatric patients.
    Preciado DA
    Int J Pediatr Otorhinolaryngol; 2012 Mar; 76(3):319-21. PubMed ID: 22264818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hearing and ossicular chain preservation in cholesteatoma surgery.
    Obholzer R; Ahmed J; Warburton F; Wareing MJ
    J Laryngol Otol; 2011 Feb; 125(2):147-52. PubMed ID: 20950509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using surgical observations of ossicular erosion patterns to characterize cholesteatoma growth.
    Maresh A; Martins OF; Victor JD; Selesnick SH
    Otol Neurotol; 2011 Oct; 32(8):1239-42. PubMed ID: 21921854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel cholesteatoma-related gene expression signatures using full-genome microarrays.
    Klenke C; Janowski S; Borck D; Widera D; Ebmeyer J; Kalinowski J; Leichtle A; Hofestädt R; Upile T; Kaltschmidt C; Kaltschmidt B; Sudhoff H
    PLoS One; 2012; 7(12):e52718. PubMed ID: 23285167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of tumor necrosis factor-alpha (TNF-alpha) in bone resorption present in middle ear cholesteatoma.
    Vitale RF; Ribeiro Fde A
    Braz J Otorhinolaryngol; 2007; 73(1):117-21. PubMed ID: 17505610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.